论文部分内容阅读
目的观察腺苷蛋氨酸联合门冬氨酸钾镁治疗急慢性重型黄疸型肝炎、肝硬化的临床疗效。方法将100例急慢性重型黄疸型肝炎、肝硬化患者,随机分为治疗组和对照组各50例,腺苷蛋氨酸联合门冬氨酸钾镁为治疗组,促肝细胞生长素联合门冬氨酸钾镁为对照组,对两组治疗后疗效进行比较。结果治疗组疲乏、腹胀消失,食欲增加,临床症状迅速改善,黄疸消退较快,肝功能明显好转,阻止了病情发展与肝细胞进一步坏死,减少了肝硬化并发症及肝细胞性肝癌的发生。结论应用腺苷蛋氨酸联合门冬氨酸钾镁治疗急慢性重型黄疸型肝炎、肝硬化,退黄效果明显优于对照组。
Objective To observe the clinical efficacy of adenosylmethionine combined with potassium and magnesium aspartate in the treatment of acute and chronic severe jaundice hepatitis and cirrhosis. Methods 100 cases of acute and chronic severe jaundice hepatitis and liver cirrhosis were randomly divided into treatment group and control group, 50 cases each. Adenosine methionine combined with potassium and magnesium aspartate as the treatment group, hepatocellular growth hormone combined with aspartate Potassium and magnesium for the control group, the efficacy of the two groups were compared after treatment. Results The treatment group was tired, abdominal distension disappeared, appetite increased, clinical symptoms improved rapidly, jaundice subsided quickly, and liver function improved significantly, preventing the progression of the disease and further necrosis of hepatocytes, reducing the incidence of liver cirrhosis and hepatocellular carcinoma. Conclusions The application of adenosylmethionine combined with potassium and magnesium aspartate in the treatment of acute and chronic severe jaundice hepatitis has better effect than cirrhosis and yellowing treatment.